Navigation Links
NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
Date:9/7/2007

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to our ability to successfully develop early detection diagnostic products for lung cancer and Melanoma in collaboration with NYU Medical Center, the role of miRNAs in human physiology and disease, and the potential of microRNAs in the diagnosis and treatment of disease, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover and develop novel diagnostics products, which is unproven and may never lead to marketable products; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; obtaining, maintaining and protecting intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; the successful development of Rosetta's product candidates, all of which are in early stages of development; obtaining regulatory approval for products; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those risks more fully discussed in the "Risk Factors" section of Rosetta's most recent Registration Statement on Form F-1 on file with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of today and
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 The chemistry, taste, and health ... a new article published by the nonprofit American Botanical Council ... climate change and its effects on the phytochemical compounds in ... study conducted by Dr. Ahmed in the Yunnan ... and has implications for the future of medicinal botanicals. Dr. ...
(Date:9/15/2014)... septembre 2014 La deuxième édition annuelle ... (semaine internationale sur la sensibilisation au plasma) sera ... de la Plasma Protein Therapeutics Association ... l,IPAW vise à : , Sensibiliser ... collecte du plasma-aphérèse , Reconnaître la contribution ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Hydro ... ) announced today that it will be partnering ... CA ( http://www.proteaf.com ) for implementing its Shock ... value continuous processing. Continuous flow chemistry through ... chemical, pharmaceutical and petrochemical markets for decades. ...
(Date:9/14/2014)... Bacteria are particularly ingenious when it comes to survival ... from a hostile environment, for example during treatment with ... surrounded by a protective slime capsule consisting of sugar ... Universiteit Brussel have for the first time created a ... curli building blocks cross the bacterial cell wall, a ...
Breaking Biology Technology:Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2New insights in survival strategies of bacteria 2
... April 14 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ... financial results of the fiscal 2009 third quarter and ... the year-end results for its fiscal year 2009 now ... for the three-month period ended February 28, 2009 in ...
... April 13, 2009 Applied scientists at the Harvard ... with researchers from Hamamatsu Photonics in Hamamatsu City, Japan, ... the direction of oscillation of the emitted radiation, known ... The innovation opens the door to a wide range ...
... Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., ... mL in PVC flexible containers to its existing Fluconazole ... is equivalent to Diflucan(R) by Pfizer. Fluconazole injection ... candidiasis, cryptococcal meningitis, and is also indicated for the ...
Cached Biology Technology:Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 2Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 3Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 4Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 5Scientists demonstrate laser with controlled polarization 2Bedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers 2
(Date:9/15/2014)... life it,s not what comes to mind when you ... of Doncaster,s 310-million-year-old past, including a fossilised shark egg case, ... of the fossilised plants and creatures may even be new ... horseshoe crabs and some previously unrecorded seed pods are amongst ... formed within the coal and shale deposits in what is ...
(Date:9/15/2014)... balance between ridding the body of a dangerous virus ... appearing in The Journal of Experimental Medicine ... chronic infections in roughly three-quarters of infected people, putting ... cirrhosis and cancer. A few patients successfully eliminate infection, ... T cells. The protective effects of CD8 + ...
(Date:9/15/2014)... Ore. Amid conflicting reports about the need for ... analysis published today suggests that adequate levels of this ... the elderly, and women who are or may become ... is also important, researchers said, but often complicated by ... most difficult to obtain through diet alone. It has ...
Breaking Biology News(10 mins):'Jaws' lived in Doncaster 2Vitamin E intake critical during 'the first 1,000 days' 2Vitamin E intake critical during 'the first 1,000 days' 3
... & IRRI (The International Rice Research Institute) today announced ... a new strategy that will galvanize agricultural research focused ... by a 2.55M USD grant to CAMBIA from The ... Initiative ?Biological Innovation for Open Society- is often called ...
... from researchers at Harvard Medical School and Massachusetts Institute ... Cancer Conference (ECCO) have shown for the first time ... , Nucleic acid ligands (referred to as aptamers) ... to target antigens with high specificity and affinity; analogous ...
... standard Internet protocol that checks errors made during ... to transform DNA microarray analysis, a common technology ... which blends experiment and computation, strengthens DNA microarray ... who is publishing his findings in the December ...
Cached Biology News:Open Source Biotechnology alliance for international agriculture 2Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 2Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 3Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 4Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool 2Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool 3
...
D.R. Harper (1993) • Includes: essential information on taxonomy, culture and safe handling of viruses, immunology, monoclonal antibodies, antivirals and vaccines....
... (1995) • This book is unique ... and molecular techniques currently used in ... analysis of virus-specific antibodies and clinical ... covering immunoassays, blotting and hybridization procedures, ...
Bovine Serum...
Biology Products: